Boston Scientific EKOS System Outperforms Standard Care in Pulmonary Embolism Treatment: HI-PEITHO Trial Results

Boston Scientific's EKOS Endovascular System showed superiority in treating acute pulmonary embolism in a global randomized clinical trial. The study demonstrated that the EKOS system plus anticoagulation was superior to anticoagulation alone for patients with intermediate-risk pulmonary embolism. The EKOS system delivers clot-dissolving medication directly to the blood clot and uses ultrasound energy to facilitate dispersion into the clot.